Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Cancer (NSCLC): early-phase trial registry
8 of 8 indexed Lung Cancer (NSCLC) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 8 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Lung Cancer (NSCLC): 8 US clinical trials tracked, 8 recruiting.
Lung Cancer (NSCLC) is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Ballad Health, running 1 of these trials.
Enrollment posture brief
Registry condition lung-cancer-nsclc
OPEN 8 | RECR 100% | LATE 0 | EARLY 5 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Lung Cancer (NSCLC) lists 8 open slots (100% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lung Cancer (NSCLC) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lung Cancer (NSCLC) is recruiting above its size-band peers.
8 of 8 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Lung Cancer (NSCLC) trials is spread across many organizations.
Ballad Health accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Lung Cancer (NSCLC) enrolment sits around 194 participants.
Median target enrolment is 194 among the 8 trials that report a genuine target (sentinel values excluded). 3 of those (37.5%) plan for fewer than 100 participants.
-
Lung Cancer (NSCLC) research is mostly interventional.
8 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Revolution Medicines
NCT07349537
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Krystal Biotech
NCT06228326
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Phrontline Biopharma
NCT07181473
Engagement of Veterans With Lung Cancer
Palo Alto Veterans Institute for Research
NCT07219251
A Study of PHN-012 in Patients With Advanced Solid Tumors
Pheon Therapeutics
NCT07127874
Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
Brigham and Women's Hospital
NCT06987890
A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.
The Christ Hospital
NCT07207395
Study of Longitudinal Plasma PD-L1 Testing With Immunotherapy in Lung Cancer
Ballad Health
NCT06849518
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Lung Cancer (NSCLC) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lung Cancer (NSCLC) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lung Cancer (NSCLC) page
8 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Lung Cancer (NSCLC) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Ballad Health sponsors the most Lung Cancer (NSCLC) trials on record, review their full trial history before evaluating a specific study. See Ballad Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lung Cancer (NSCLC) condition card totals 8 registered trials; most-linked intervention Circulogene liquid biopsy testing; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.